Latest Breaking News On - Regain compliance - Page 1 : comparemela.com

Scinai Immunotherapeutics : Announces Receipt of Nasdaq Delisting Notification and Appeal

The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares Designed to Regain Compliance JERUSALEM, ISRAEL -May 6th, 2024 - Scinai.

Israel generalScinai bioservicesScinai immunotherapeuticsNasdaq stock marketListing qualifications department the staffScinai immunotherapeutics ltdBusiness developmentCompany american depositary shares adssCompany contactsNasdaq hearings panel theRatio changeNon traded ordinary sharesRegain complianceListing qualifications departmentNasdaq listing ruleAmerican depositary shares

Scinai Immunotherapeutics : The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance - Form 6-K

Scinai Immunotherapeutics : The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Israel generalScinai immunotherapeuticsScinai bioservicesCompany contactsCompany american depositary shares adssScinai immunotherapeutics ltdNasdaq hearings panel theListing qualifications department the staffNasdaq stock marketBusiness developmentRatio changeNon traded ordinary sharesRegain complianceListing qualifications departmentNasdaq listing ruleAmerican depositary shares

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesRobin yangAlyssa liSecurities exchangeNasdaq stock marketPrnewswire ys biopharma co ltdRsys groupSource ys biopharma co ltdExchange commissionCompany registration statement on formReceives additionalRegain complianceMinimum bid priceNasdaq listing ruleNasdaq capital marketBid price requirement

Wearable Devices Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Wearable Devices Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ha afonWalter frankWearable devices ltdNasdaq stock marketExchange commissionSecurities exchangeDevices grantedDay extensionRegain complianceMinimum bidImmediate effectNasdaq listingWearable devicesNasdaq capital marketListing rulesMudra band

NuZee, Inc Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)

NuZee, Inc Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Nuzee incListing qualifications panelNasdaq stock marketSecurities exchangeApproved extensionRegain complianceNasdaq listing ruleNasdaq capitalNasdaq capital marketEquity requirementListing qualificationsLooking statementsSecurities actSecurities exchange actRisk factorFinancial condition